13 Ways To Create A Sustainable Biosimilars Market In Europe

 
• By Ian Schofield

More alignment between manufacturers and national payers is needed on issues such as price, competition and the role of payer guidance if the biosimilars market is to be sustainable over the longer term, says a new report.

businessman and businesswoman are exchanging document or contract
Biosimilar companies and payers need to find common ground on key issues

More from Biosimilars

More from Biosimilars & Generics